• 国家药监局综合司 国家卫生健康委办公厅
  • 国家药监局综合司 国家卫生健康委办公厅

Exploring the Molecular Mechanism of Fengliao Changweikang in the Treatment of Irritable Bowel Syndrome Based on Network Pharmacology and Molecular Docking Technology

Corresponding author: WU Xiayang, 56425477@qq.com
DOI: 10.12201/bmr.202504.00022
Statement: This article is a preprint and has not been peer-reviewed. It reports new research that has yet to be evaluated and so should not be used to guide clinical practice.
  •  

    Abstract: Objective: Predicting the target and mechanism of Fengliao Changweikang in treating irritable bowel syndrome based on network pharmacology and molecular docking technology. Method: Screening the effective components of Fengliao Changweikang through data mining, constructing a drug-target network using STRING and Cytoscape software to identify key targets and pathways related to irritable bowel syndrome. Perform molecular docking verification on the main active components and core action target proteins, evaluate the binding energy, and process the results for visualization. Results: Obtained 24 potential active components of Fengliao Changweikang, 134 active component target sites, 2353 disease-related target sites. After intersection, 70 potential target sites were obtained, involving 898 biological processes, 96 molecular functions, and 66 cellular components. KEGG enrichment analysis indicates that the therapeutic mechanism of Fengliao Changweikang for irritable bowel syndrome may be achieved by acting on core target points to participate in the regulation of cancer pathways, PI3K/Akt signaling pathways, phospholipase D pathways, and other key signaling pathways. Molecular docking analysis results show that the core compounds in Fengliao Changweikang have good binding activity with the core receptor protein. Conclusion: This study predicts the potential effective components, action targets, and mechanisms of Fengliao Changweikang in treating irritable bowel syndrome through network pharmacology, which can provide theoretical guidance and prediction for further research, but more relevant experiments are still needed for verification in the later stage.

    Key words: Fengliao Changweikang; network pharmacology; irritable bowel syndrome; molecular docking; Target prediction

    Submit time: 9 April 2025

    Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
  • 图表

  • Wei Chunshan. Exploring medication rules and mechanism for liver cancer based on data mining and network pharmacology. 2024. doi: 10.12201/bmr.202407.00040

    LIANG Ningjuan, WU Ting, YU Dandan, JIANG Xiaohan, TENG Jingjing. Effective exploration of the toxicity and molecular mechanisms of plasticisers in pulmonary fibrosis by network toxicology and molecular docking strategies: an example of butylbenzyl phthalate. 2025. doi: 10.12201/bmr.202504.00004

    Yuan Zhenzhong. Mechanism of Relieves insomnia Effect of Jiaotai Pills Based on Network Pharmacology. 2024. doi: 10.12201/bmr.202408.00069

    TANG Shishi, ZHOU Yi. Research on Hemorrhagic Fever with Renal Syndrome Incidence Prediction Based on the SARIMA-LSTM Model. 2024. doi: 10.12201/bmr.202407.00046

    A Study on the Prediction of Acute Coronary Syndrome Based on Coronary Fat Attenuation Index and Laboratory Indicators. 2024. doi: 10.12201/bmr.202409.00001

    XuHong. Advances in the treatment of osteopenia-seropathic obesity syndrome in the elderly. 2024. doi: 10.12201/bmr.202411.00064

    Zhang Han, Chu Mengyuan, Xu Kaikai, Xiang Xin, Yan Ying. Progress in Mechanism of Action of Isthmin1 Protein in Polycystic Ovary Syndrome. 2024. doi: 10.12201/bmr.202411.00004

    Zhang Chunyang, Hu Hongwei. Research on the prediction mechanism of working ability of elderly nursing staff based on neural network: Perspective of professionalization. 2021. doi: 10.12201/bmr.202104.00022

    YANG Xiaotong, LI Yifan, JI Wei. Visualization analysis of traditional Chinese medicine in the prevention and treatment of Sj?grens syndrome. 2025. doi: 10.12201/bmr.202502.00032

    Zhang zhenwen. Effects of SGLT2 inhibitors on the metabolic syndrome and its components. 2025. doi: 10.12201/bmr.202503.00002

  • ID Submit time Number Download
    1 2025-03-24

    bmr.202504.00022V1

    Download
  • Public  Anonymous  To author only

Get Citation

HONG Suru, WU Xiayang. Exploring the Molecular Mechanism of Fengliao Changweikang in the Treatment of Irritable Bowel Syndrome Based on Network Pharmacology and Molecular Docking Technology. 2025. biomedRxiv.202504.00022

Article Metrics

  • Read: 88
  • Download: 0
  • Comment: 0

Email This Article

User name:
Email:*请输入正确邮箱
Code:*验证码错误